Abstract
BackgroundSulfite oxidase deficiency (SOD) is a rare neurometabolic inherited disorder causing severe delay in developmental stages and premature death. The disease follows an autosomal recessive pattern of inheritance and causes deficiency in the activity of sulfite oxidase, an enzyme that normally catalyzes conversion of sulfite to sulfate. Aim of the studySOD is an underdiagnosed disorder and its diagnosis can be difficult in young infants as early clinical features and neuroimaging changes may imitate some common diseases. Since the prognosis of the disease is poor, using exome sequencing as a powerful and efficient strategy for identifying the genes underlying rare mendelian disorders can provide important knowledge about early diagnosis, disease mechanisms, biological pathways, and potential therapeutic targets. Patients and methodsIn this study, a case who was a newborn infant boy with suspected SOD and his healthy parents were recruited for exome sequencing. The first laboratory reports of the patient were positive urine sulfite, elevated urinary thiosulfate, and high levels of plasma lactate and pyruvate. The patient also presented some symptoms such as intractable seizures, abnormal tone, feeding difficulties, profound mental retardation, abnormal respiratory drive, aspiration pneumonia, microcephaly, and dislocated ocular lenses. The genomic DNA of the patient and his parents was extracted from peripheral blood lymphocytes as targets for exome sequencing, performed by Axeq Technologies (Amsterdam, the Netherlands). ResultsThe results showed no single predominate mutation in the SUOX gene as one of the candidate genes involved in the catabolism of sulfur-containing amino acids. The same results obtained in the molybdenum cofactor biosynthetic genes (MOCS1, MOCS2, and GEPH genes). Instead, the results revealed that causal variations are present in genes underlying in different biochemical pathways among which the sulfur metabolism, signaling and signal transduction, and transcription pathways are of higher importance. ConclusionIn this study, several classes of genes were introduced as candidate genes involved in SOD. However, further studies are necessary to examine the reported genes in more details on how these genes may relate to each other and contribute to the pathology of SOD disease.
Highlights
Sulfite oxidase deficiency (SOD) is an inherited disease which causes neurometabolic abnormalities due to changes in sulfated amino acid metabolism and leading to early death [1]
The results showed no single predominate mutation in the sulfite oxidase gene (SUOX) gene as one of the candidate genes involved in the catabolism of sulfur-containing amino acids
The same results obtained in the molybdenum cofactor biosynthetic genes (MOCS1, MOCS2, and GEPH genes)
Summary
Sulfite oxidase deficiency (SOD) is an inherited disease which causes neurometabolic abnormalities due to changes in sulfated amino acid metabolism and leading to early death [1]. Based on the recent researches, causative mutations have been identified in MOCS1, MOCS2, and GEPH, and a total of 32 different disease-causing mutations have been detected in molybdenum cofactor-deficient patients and their relatives [11]. The first study to determine if it was possible to identify causal genetic variants using ES was carried out in 2009 for detection of the Freeman–Sheldon Syndrome (FSS) (OMIM 193700) [13]. This experiment helped to confirm that ES can be used to identify causal variants of rare genetic disorders, especially unknown causal genes for rare Mendelian diseases. The disease follows an autosomal recessive pattern of inheritance and causes deficiency in the activity of sulfite oxidase, an enzyme that normally catalyzes conversion of sulfite to sulfate
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.